MATROS RICHARD K, Chairman, CEO and President, subtracted 113,000 shares of Sabra Health Care REIT, Inc. (SBRA) from its portfolio at the rate of $24.05 per share valuing $2,717,277 on Nov 04. The insider left behind 959,989 shares of the company to its portfolio. Currently, the 1st Resistance Point for this stock is $22.13, with a 2nd Resistance Point sitting at $22.58. Meanwhile, this company’s stock has a 1st Support Level at $21.42 and a 2nd Support Level at $21.16. Before making a move on any particular stock, readers often pay close attention to support and resistance markers. The last reported price for shares of Sabra Health Care REIT, Inc. (SBRA) was $21.67. Sabra Health Care REIT, Inc. (SBRA) stock has lost -$0.01, or -0.82%, in the past five days. In the last full month, these shares have lost -$2.66, or -10.93%. In the past three months, this stock’s price has risen by $0.05, or 0.23%. This year-to-date, Sabra Health Care REIT, Inc. (SBRA) shares have gained $5.19, or 31.49%.
Analyzing price projection indicators is a helpful way to determine whether a potential stock buy is a wise choice for profits in the short term, medium term, and long term. For Sabra Health Care REIT, Inc. (SBRA) stock, Hold % of short-term indicators suggest that these shares are a “ Sell .” Meanwhile, 50% of medium-term indicators point to this stock being a “ Buy .” Looking further ahead, 50% of long-term indicators suggest that this stock is a “ Buy .”
With 193,697 K shares outstanding, this company currently has a market capitalization of $4,315,570K. Sabra Health Care REIT, Inc. (SBRA) generates $623,410 K in annual sales, amounting to annual net income of $279,080 K. This stock has generated a 1-Year Total Return of 12.34%, a 3-Year Total Return of -0.40%, and a 5-year Total Return of -19.83%. This stock’s 5-Year Dividend Growth is 32.35%, with its most recent dividend valued at $0.450 per share on 11/14/19. Its Annual Dividend Yield is 8.08%, and its Annual Dividend Rate is 1.80.
In the most recently-reported fiscal quarter, which ended in 09/19, Sabra Health Care REIT, Inc. (SBRA) reported earnings of $0.47 per share. Wall Street analysts, on average, were expecting the company to report earnings of $0.46 per share, representing a 0.01 difference and 2.17% surprise. In the previous quarter ending in 06/19, the reported earnings of $0.46 represented a -0.01 difference from the consensus estimate calling for $0.47 per share, which was a -2.13% surprise.
For the current fiscal quarter, which is set to end in 12/2019, the average earnings estimate is $0.45 per share. This estimate came from a total of 5 Wall Street Analysts. Of those market experts, the high estimate was $0.47 and the low estimate was $0.43. In the year-ago quarter, Sabra Health Care REIT, Inc. (SBRA) generated per-share earnings of $0.50. If the analysts are correct about the current quarter’s earnings, the growth will be -10.00%.
Turning our focus now to insider trading activity, there have been 2 purchases (2,176 shares in total) and 1 sale (113,000 shares in total) in the last 3 months. In the last 6 months, there have been 23 insider buys amounting to 64,086 shares and 3 insider sales amounting to 186,000 shares. In the past full year, 61 insider purchases were made (involving 448,760 shares) and 15 insider sell-offs equivalent to 295,567 shares.
Looking at this company’s capital structure, its Total Debt to Total Equity is 99.43, its Total Debt to Total Capital is 49.86, and its Total Debt to Total Assets is now 48.49. Looking even further ahead into the future, its Long-Term Debt to Equity is 2.05 and its Long-Term Debt to Total Capital is 99.33.